May 7 (Reuters) - Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by ...

Huggies maker Kimberly-Clark announced Monday it will buy Tylenol’s parent company Kenvue in a nearly $50 billion deal, creating a massive consumer products conglomerate. The merger is the latest in a ...

Consumer-goods giant Kimberly-Clark Corp. announced Monday a deal to buy Kenvue Inc., ending months of speculation about the future of the embattled maker of Tylenol, Band-Aid and Listerine. Even ...

Kimberly-Clark will acquire Kenvue in a deal valued at nearly $49 billion, both companies announced Monday, combining the maker of Huggies diapers and Kleenex with the owner of Tylenol, which has ...

Kimberly-Clark announced Monday it's struck an agreement to buy Kenvue in a deal valued at $48.7 billion. The combined company would bring together brands like Huggies and Kleenex with the likes of ...

We all have childhood memories of runny noses, skinned knees, and comforting care from mom and dad. The products that populate those memories are American classics like Kleenex, Neosporin, and ...

Kimberly-Clark Corporation (Nasdaq: KMB) today reported first quarter 2026 results driven by resilient consumer demand for the company's brands, the introduction of pioneering innovative new products, ...

Consumer giant Kimberly-Clark, which makes Huggies diapers and Kleenex tissues, is buying the company that makes Tylenol and Band-Aids in one of the biggest mergers of the year. The deal, worth almost ...

The maker of Kleenex tissues and Huggies diapers reported a profit of $665 million, or $2 a share. That compares with a ...

Kenvue's stock, which had hit a record low in recent weeks, was headed for its best day ever, while Kimberly-Clark's stock tumbled Consumer goods giant Kimberly-Clark Corp. is buying Tylenol maker ...